Lundbeck announces headline results from Phase IV THRIVE trial evaluating VYEPTI® (eptinezumab) following inadequate response to prior CGRP-targeting preventive therapy

- Primary endpoint analysis of the clinical Phase IV THRIVE trial showed that 60% of participants reported being 'much improved' or 'very much improved' following treatment with eptinezumab

- Results provide prospective clinical data on the use of eptinezumab in adults with migraine following inadequate response to one prior CGRP-targeting preventive therapy

- Eptinezumab was generally well tolerated with no new safety signals identified in this population

- Full results from the trial will be presented at upcoming scientific congresses

VALBY, Denmark, Oct. 1, 2026 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) today announced headline results from the Phase IV interventional, open-label THRIVE trial (NCT06701526), evaluating eptinezumab in adults with migraine who had experienced an inadequate response to one prior calcitonin gene-related peptide (CGRP)-targeting preventive therapy.

THRIVE is the first interventional trial specifically designed to evaluate outcomes after treatment with eptinezumab in people with migraine who had experienced inadequate response to one previous CGRP-targeting preventive therapy. The trial addresses an important evidence gap, as there is currently limited clinical data to inform treatment sequencing for patients who received prior migraine preventive therapies.

In the THRIVE trial, participants received eptinezumab 100 mg at baseline, followed by dose escalation to 300 mg at week 12. At week 12, 44% of participants remaining in the trial reported being 'much improved' or 'very much improved' on the Patient Global Impression of Change (PGIC). At week 24, the trial's primary endpoint, 60% of participants remaining in the trial reported being 'much improved' or 'very much improved'.

"These results provide important prospective clinical trial data for people who continue to experience substantial migraine burden despite treatment with a prior CGRP-targeting preventive therapy," said Tarek Samad, Executive Vice President and Head of Research and Development at Lundbeck. "THRIVE was designed to help answer a clinically relevant question about what may come next for these patients, and these encouraging results add to the growing body of evidence supporting eptinezumab in migraine prevention. This is an important part of our continued commitment to helping more people achieve better control of this disabling neurological disease."

Reductions across monthly migraine days, monthly headache days, and acute medication use were also assessed, alongside measures of migraine-related burden. These findings will add further perspective to the overall improvement reported by participants on the PGIC. In addition, eptinezumab was well tolerated with no new safety signals identified in this patient population experiencing previous inadequate response to CGRP-targeting treatments.

Full results from THRIVE will be submitted for presentation at a future scientific congress and publication in a peer-reviewed journal.

About migraine

Migraine is a complex and disabling neurological disease characterized by recurrent attacks of severe headache typically accompanied by an array of symptoms, including nausea, vomiting, and sensitivity to light and sound. The disease can have a profound impact on daily functioning, work productivity, family, and social relationships and quality of life.

Migraine is one of the most prevalent neurological diseases worldwide and remains a leading cause of disability, particularly among people under the age of 50.1,2 As migraine frequency and severity increase, attacks may become harder to control, contributing to greater disease burden and, without appropriate preventive management, progression to chronic migraine.3

Despite recent advances in migraine-specific prevention, some patients continue to experience substantial migraine burden after an inadequate response to CGRP-targeting preventive therapies. Real-world studies of anti-CGRP monoclonal antibodies and preventive gepants have reported treatment discontinuation rates of approximately 40–45%, with inadequate effectiveness among the main reasons for discontinuation.4,5

About the THRIVE trial

The THRIVE trial was a 24-week, Phase IV, open-label, multicenter, interventional trial conducted in the United States evaluating the effectiveness and safety of eptinezumab in adults with migraine who had an inadequate response to one prior CGRP-targeting preventive therapy. The study enrolled 164 adults with at least eight monthly migraine days (MMD) who had previously received either a subcutaneous anti-CGRP monoclonal antibody or preventive gepant and had not received eptinezumab. All participants initiated eptinezumab 100 mg and subsequently escalated to 300 mg at Week 12 (147 participants received two infusions), and 84% (138/164) of participants completed the trial.

The primary endpoint was the proportion of participants reporting 'much improved' or 'very much improved' on the 7-point Patient Global Impression of Change (PGIC) scale (comprising 'very much improved', 'much improved', 'minimally improved', 'no change', 'minimally worse', 'much worse', or 'very much worse') at Week 24. Secondary endpoints included reductions in MMDs, ≥50% MMD responder rate, patient-reported outcomes assessing changes in migraine burden (including MIDAS, number of good days, brain fog as well as goal attainment scaling [GAS], a novel endpoint in migraine trials). Safety and tolerability of eptinezumab were evaluated through assessment of adverse events and vital signs during the trial.

About Vyepti® (eptinezumab)

Eptinezumab is a humanized monoclonal antibody that binds to CGRP and was intentionally designed for intravenous administration. The efficacy and safety of eptinezumab were evaluated in two Phase III clinical trials, PROMISE-1 in episodic migraine6 and PROMISE-2 in chronic migraine.7 In both trials, eptinezumab met its primary endpoint of decrease in monthly migraine days (MMDs) over weeks 1-12.

The safety of eptinezumab was evaluated in more than 2,000 adult patients with migraine who received at least one dose of eptinezumab. The most common adverse reactions (≥2% and at least 2% or greater than placebo) in the clinical trials for the preventive treatment of migraine were nasopharyngitis and hypersensitivity. Approximately 8% of patients on 300 mg, 6% of patients on 100 mg and 6% of patients on placebo in PROMISE-1 and PROMISE-2 experienced nasopharyngitis. In PROMISE-1 and PROMISE-2, 1.9% of patients treated with eptinezumab discontinued treatment due to adverse reactions.

Since launch, the safety of eptinezumab has been evaluated in more than 5,000 adult patients with migraine who received at least one dose in the placebo-controlled clinical trials for the preventive treatment of migraine. Common adverse reactions were hypersensitivity and infusion-related reactions.

VYEPTI® (eptinezumab-jjmr) was approved by the U.S. Food and Drug Administration (FDA) for the preventive treatment of migraine in adults in February 2020, and in January 2022, eptinezumab was granted marketing authorization by the European Commission (EC) for the prophylaxis of migraine in adults who have at least four migraine days per month. Today, eptinezumab is launched in more than 30 markets worldwide.

Contacts

About H. Lundbeck A/S

Lundbeck is a biopharmaceutical company focusing exclusively on brain health. With more than 70 years of experience in neuroscience, we are committed to improving the lives of people with neurological and psychiatric diseases.

Brain disorders affect a large part of the world's population, and the effects are felt throughout society. With the rapidly improving understanding of the biology of the brain, we hold ourselves accountable for advancing brain health by curiously exploring new opportunities for treatments.

As a focused innovator, we strive for our research and development programs to tackle some of the most complex neurological challenges. We develop transformative medicines targeting people for whom there are few or no treatments available, expanding into neuro-specialty and neuro-rare from our strong legacy within psychiatry and neurology.

We are committed to fighting stigma and we act to improve health equity. We strive to create long term value for our shareholders by making a positive contribution to patients, their families and society as a whole.

Lundbeck has more than 5,000 employees in more than 20 countries and our products are available in more than 80 countries. For additional information, we encourage you to visit our corporate site www.lundbeck.com and connect with us via LinkedIn.

References

- Steiner TJ, et al. J Headache Pain. 2018;19(1):17

- Leonardi M, et al. J Headache Pain. 2005; 6(6):429– 440

- Lipton RB, et al. J Neurol. 2023;270(12);5692–5710

- Buse DC, et al. Neurol Ther. 2026;15(1):401–420

- Gago-Veiga AB, et al. J Headache Pain. 2026

- Ashina M, et al. Cephalalgia. 2020;40(3):241-254

- Lipton RB, et al. Neurology. 2020;94(13):e1365-e1377

CONTACT: 

H. Lundbeck A/S

Ottiliavej 9, 2500 Valby, Denmark

+45 3630 1311

[email protected] 

This information was brought to you by Cision http://news.cision.com

The following files are available for download:

Share this article

Tres Agaves Tequila Launches in UK, Ireland and Continental Europe

Family-Owned Brand Brings Single-Source Organic Tequila to New Shores

ST. HELENA, Calif., Oct. 1, 2026 /PRNewswire/ -- Tres Agaves Tequila, the family-owned, 100% de Agave producer from Mexico's Tequila Valley, is launching in the UK and Ireland on October 1st, its first move into the European on-premise and independent retail trade. The rollout continues into Germany, Switzerland, the Nordics and Spain in the months that follow, with a formal European trade introduction at Bar Convent Berlin in mid-October.

Tres Agaves distills every drop from a single source in Amatitán, the birthplace of Tequila, built on nearly two decades of direct relationships with local growers. That single-estate sourcing, paired with USDA and Mexican organic certification and NOM-registered production, has made the brand a fixture behind U.S. bars. The UK and Ireland launch brings the same proposition to European bartenders and independent retailers for the first time.

"Tequila is one of the fastest-growing spirits categories in Europe, and bartenders want brands with real provenance," said Thomas Vogele, Vice President International Sales for Trinchero Family Wine & Spirits. "Tres Agaves gives the trade an organic, single-source Tequila from a genuinely family-owned producer, at a price accessible for the back bar rather than the top shelf."

The European Tequila market is set to reach a revenue of $2.49 billion by 2030, with a compound annual growth rate of 9.6% between 2025 and 2030. Tres Agaves is up +769% FYTD in the Trinchero Export Division. ¹ Stateside, Tres Agaves was recently named to Shanken's Impact 2026 "Hot Prospects" list, recognizing it among the fastest-growing spirits brands in the U.S.² Against this backdrop of growth, Tres Agaves is thrilled to offer its organic Tequila range to bartenders and consumers in the UK and Ireland and bring even more momentum to this vibrant category.

Launching in the UK & Ireland:

- Tres Agaves Blanco Tequila: unaged, bottled immediately after distillation; roasted agave, mint, citrus and pear.

- Tres Agaves Reposado Tequila: nine months in Tennessee whiskey and bourbon barrels; agave-forward with citrus, spice and baked tropical fruit. Wine Enthusiast Top 100 Spirit of the Year.

- Añejo and Extra Añejo: limited allocation for bars and retailers.

- Cocktail Mixers and Agave Nectar: USDA-certified organic Margarita and Bloody Mary mixes, plus cocktail-ready agave nectar.

Blanco and Reposado launch in a 700 ml pack size to meet European market requirements with suggested retail pricing ranging from £40-£45. Tres Agaves is exported by Trinchero Family Wine & Spirits.

¹ Source: Circana, Total MULO + with Conv + LIQ; L26wks ending 8/03/26

² Source: Shanken News Daily, "Exclusive: RTDs, Tequila Drive Lead Impact's 'Hot Prospects' List," September 14, 2026.

About Tres Agaves

Tres Agaves produces award-winning 100 percent de Agave Tequilas and USDA Organic cocktail mixers. Tres Agaves Tequilas are produced in the Tequila Valley using time-honored traditions. Its mixers are USDA certified organic, gluten-free and sweetened only with the finest blue weber agave nectar, making them the perfect choice for health and calorie conscious consumers. Tres Agaves cocktail-ready agave nectar, lime margarita, strawberry margarita, and Bloody Mary mixers were carefully formulated to help people make the most delicious cocktails possible by enhancing rather than overwhelming the flavors of high-quality Tequila. Visit www.tresagaves.com to learn more.

About Trinchero Family Wine & Spirits 

A family-owned company for more than 75 years, Trinchero Family Wine & Spirits comprises more than 50 award winning wine and spirits brands distributed globally. Founded in 1948 – when Italian immigrants Mario and Mary Trinchero moved their young family from New York City and purchased the Suter Home winery in St. Helena – Trinchero Family Wine & Spirits remains rooted in Napa Valley. From these humble beginnings Trinchero has grown to become one of the five largest US wineries through strategic partnerships and investments in technology and vineyards, all while maintaining a steadfast commitment to quality, value, sustainability and philanthropy. Learn more at www.tfewines.com.

Share this article

ICEYE and Nokia partner to launch secure and sovereign satellite communications for governments and defense customers

Sovereign, dual-use satellite communications systems owned and operated by the nations that use them.

HELSINKI, Oct. 1, 2026 /PRNewswire/ -- ICEYE, the European leader in sovereign intelligence from space, and Nokia, a global leader in connectivity infrastructure, today announced a partnership to develop secure, sovereign and high-performance broadband low Earth orbit (LEO) satellite communications systems for governments, supporting missions from defense and border security to emergency services and disaster response. Built on trusted European technology, the jointly developed satellite communications systems will give nations ownership and control of the satellites, ground segment and terminals. The first communications satellites are expected to be launched in 2028.

When terrestrial networks are disrupted or compromised, defense forces, first responders and civil authorities risk losing access to the information and command systems they depend on. Governments therefore need resilient communications infrastructure that remains available under the most demanding conditions, and that they can fully own and control.

The jointly developed sovereign systems will deliver targeted, high-throughput, low-latency connectivity over priority mission areas. Designed to complement military and commercial networks rather than replace them, it will add reach, resilience and capacity, helping governments and defense organizations maintain critical connections wherever operations take place.

The partnership brings together ICEYE's track record delivering sovereign satellite missions with Nokia's extensive experience in secure networking technologies and growing defense portfolio. Together, the companies will integrate satellites, ground infrastructure and ruggedized end-user terminals to extend ICEYE's sovereign intelligence from space business model to satellite communications.

Rafal Modrzewski, CEO and Co-founder of ICEYE, said: "Together with Nokia, we are building on our proven space intelligence expertise and delivering sovereign, high-performance satellite communications. Nations must be able to fully own and control their communications, without dependency on a foreign commercial operator's terms of service. We delivered Poland its own radar satellite system in under a year. Partnering with Nokia lets us move at a similar speed for satellite communications, on the timelines nations need."

Justin Hotard, President and CEO of Nokia, said: "Sovereign operations depend on the ability to sense, decide and act in real time. Physical AI makes that possible, but only with secure, resilient connectivity across land, sea, air and space. By bringing together Nokia's trusted networks with ICEYE's proven sovereign space capabilities, we will deliver a satellite communications capability—complementing existing terrestrial networks, and giving nations the situational awareness, connectivity, and control they need to operate with confidence in contested environments across all domains."

Modrzewski and Hotard will take the stage at the Helsinki Security Forum on October 2 for a session titled "How to Salvage Europe's Technological Sovereignty."

About ICEYE

ICEYE is the world leader in sovereign intelligence from space. We deliver persistent monitoring capabilities to detect and respond to changes in any location on Earth.

ICEYE owns the world's largest and most advanced SAR (synthetic aperture radar) satellite constellation. To our customers we provide intelligence with unmatched quality, latency and revisit times, in any weather, day or night. To governments who choose to operate their own constellation we provide this proven capability as a sovereign system.

ICEYE-built constellations serve customers in defense and intelligence, environmental monitoring, insurance and emergency management. We enable fast decisions that contribute to a safer future.

Natively European, founded in Finland. ICEYE operates globally with over 1,000 employees.

We're a growing international team of builders. iceye.com/joinus

About Nokia

Nokia is a global leader in connectivity infrastructure, enabling the AI supercycle. We build networks that connect intelligence and deliver a comprehensive connectivity solution across fixed, mobile, IP, optical, core, and data center networks. With security by design, AI-driven innovation, and AI-optimized architecture, Nokia delivers trusted infrastructure that enables AI to scale and advances connectivity to secure a brighter world.

Share this article

FORCYD expands into Switzerland and appoints Bob Dillen as Partner to lead Swiss practice

AMSTERDAM, Oct. 1, 2026 /PRNewswire/ -- FORCYD today announced its expansion into Switzerland with the opening of a new office in Zurich and the appointment of Bob Dillen as Partner leading the firm's Swiss practice.

Over recent years, FORCYD has built a reputation as Europe's premier eDiscovery, Investigations, and Cyber Forensics consultancies, growing from our Amsterdam origins to offices in Brussels, London, Frankfurt, Paris and Madrid. The relationships and standards we have developed reflect our core commitment to quality and client service.

The opening of our Zurich office enhances our ability to support clients locally in the DACH region while continuing to deliver cross-border expertise in complex legal and regulatory matters. The new office reflects the growing demand for specialist expertise in managing digital information across litigation, investigations, regulatory proceedings and other complex matters.

Bob Dillen brings more than two decades of international experience in forensic technology, eDiscovery and investigations, having advised organisations on arbitrational and dispute cases, regulatory matters and large-scale global investigations across multiple sectors.

Bas Sluijsmans, Partner and co-founder of FORCYD, comments:

"We are delighted to welcome Bob to FORCYD and to open our new office in Zurich. Bob is highly regarded in the market and brings decades of experience helping organisations navigate investigations, litigation and regulatory challenges. Just as importantly, we share the same commitment to quality, independence and client service. Bob will play a key role in our continued growth, and we look forward to building our Swiss practice and our global investigations offering together."

Bob Dillen adds:

"Having spent my career helping organisations navigate complex investigations, disputes and regulatory matters, I have seen first-hand the value of combining specialist expertise with a practical, hands-on approach. FORCYD shares that mindset, and I am delighted to join the firm and lead its Swiss practice."

About FORCYD

FORCYD offers high-end eDiscovery, cyber forensic and investigation advisory services and solutions. As an independent, globally operating consultancy with offices across Europe, FORCYD helps organisations and their advisers establish the facts and respond with confidence in matters involving misconduct, litigation, data breaches and other complex legal and regulatory challenges. We are called upon when the stakes are high, the matters complex, cross-border and time is of the essence, a trusted advisor to our clients and their legal counsels.

Share this article

Absa and Thunes Deepen Alliance to Launch World-Class Cross-Border Payments Across Africa

Strategic collaboration expands across African markets to unlock seamless FX, scalable liquidity, and multi-rail cross-border clearing for Absa clients.

JOHANNESBURG and SINGAPORE, Oct. 1, 2026 /PRNewswire/ -- Absa Group, one of Africa's largest diversified financial services providers, has selected Thunes, the Smart Superhighway to move money around the world, as a strategic Multicurrency Clearing (MCC) partner for the Group.

The new collaboration builds on the two companies' recent launch of Absa Global Pay in South Africa which demonstrated the value of combining Absa's strong banking franchise and Pan-African reach with Thunes' global payment connectivity and local-market capabilities. The expanded relationship will now support Absa's broader cross-border payments strategy across Africa and global markets.

Multicurrency Clearing forms a fundamental pillar of Absa's strategy to deliver greater speed, transparency, and choice in cross-border payments. By linking Absa's Pan-African banking footprint directly to Thunes' Direct Global Network, which spans over 140 countries, 90 currencies, and 220 payment methods, the collaboration enables seamless payouts beyond bank accounts to mobile wallets and card rails with 24/7 liquidity and enterprise-grade compliance.

Richard Southey, Managing Executive: Payments as a Service, Absa CIB, said: "Deepening our strategic collaboration with Thunes is a natural evolution of our commitment to delivering intuitive, world-class financial services. Following the success of our Global Pay solution launched with Thunes in South Africa, expanding this collaboration allows Absa to leverage Thunes' expansive and trusted Network across the continent to extend our cross-border solution, giving our clients unprecedented currency choice, speed, and cost efficiency."

Daniel Parreira, Senior Vice President, Africa at Thunes, said: "Our initial work with Absa demonstrated the tremendous impact of combining deep local banking relationships with interoperable global payment reach. By extending our collaboration and taking on a strategic Multicurrency Clearing role supporting Absa Group, we are providing the digital infrastructure and liquidity needed to connect African businesses and consumers to global payment ecosystems seamlessly."

To celebrate this milestone, executive leaders from both organisations gathered for an official signing ceremony at SIBOS 2026 in Miami.

About Thunes

For more information, visit: https://www.thunes.com/

About Absa Group Limited

Absa Group Limited ('Absa Group') is listed on the Johannesburg Stock Exchange and is one of Africa's largest diversified financial services groups.

Absa Group offers an integrated set of products and services across personal and business banking, corporate and investment banking, wealth and investment management and insurance.

Absa Group owns majority stakes in banks in Botswana, Ghana, Kenya, Mauritius, Mozambique, Seychelles, South Africa, Tanzania (Absa Bank Tanzania and National Bank of Commerce), Uganda and Zambia and has insurance operations in Kenya and South Africa. Absa also has offices in the People's Republic of China, Namibia, Nigeria and the United States, as well as securities entities in the United Kingdom and the United States, along with technology support colleagues in the Czech Republic.

For further information about Absa Group Limited, visit www.absa.africa.

SOURCE Thunes

Share this article

Three Companies Control 80% of the Prescription Market. AlignRx Built a Public Benefit LLC to Push Back, and Tells the Story on "All Access with Andy Garcia"

LOS ANGELES, Oct. 1, 2026 /PRNewswire/ -- A forthcoming feature on the public television series All Access with Andy Garcia goes behind the counter at community pharmacies, exploring the vital role pharmacists play as some of the most accessible and trusted healthcare providers—and the growing fight for fair reimbursement needed to keep these neighborhood cornerstones open.

The feature examines not only the importance of local pharmacies to an individual's health, but also what happens behind the counter after the conversation between pharmacist and patient ends. That includes navigating complex systems of insurance contracting and claims reimbursement, particularly when a pharmacy is reimbursed less than the cost of the medication it dispenses. Against this backdrop, the feature highlights the role AlignRx plays in helping community pharmacies navigate these challenges and advocate for a more transparent and sustainable reimbursement environment.

AlignRx is the nation's largest independently owned Pharmacy Services Administrative Organization (PSAO), working with community pharmacies in all 50 states and Puerto Rico. Founded in 2021 as a Public Benefit LLC—the only PSAO organized under this structure—AlignRx works to protect the future of community pharmacy by advocating for increased transparency, fair competition, pharmacy choice and patient access.

Last year, three pharmacy benefit managers—CVS Caremark, Optum Rx, and Express Scripts—processed roughly 80% of U.S. prescription claims, and this market consolidation has led to a vertically integrated system where patients can face higher out-of-pocket costs and lack of choice, potentially severing existing relationships with their trusted local pharmacists. Melanie Maxwell, president of AlignRx, describes the imbalance between community pharmacies and larger industry players as a modern-day "David and Goliath" story.

For Maxwell, the fight is personal. During the final months of her parents' lives, Maxwell found herself spending more time at a pharmacy counter than in a physician's office, asking questions someone needed to answer that day. That experience turned into a 35-year career in pharmacy and is the thread running through the forthcoming short-form documentary distributed to Public Television stations across the country.

The pressure on community pharmacies is at an all-time high and is leading to critical gaps in care for some of the nation's most vulnerable populations. Research shows pharmacies serving communities with higher concentrations of Medicaid and Medicare patients have closed at greater rates, contributing to the spread of pharmacy deserts across rural counties and urban neighborhoods alike.

"The relationship across the patient, the physician, and the pharmacist is like a three-legged stool," said Maxwell. "If you remove one of those legs, the patient—the one sitting on the stool—gets hurt. When we weaken the community pharmacy, we're not just affecting a business, we're affecting the patient who depends on that pharmacist for access, answers and care."

About "All Access with Andy Garcia": All Access with Andy Garcia is an award-winning short-form documentary series produced by a veteran team of producers and distributed to Public Television stations nationwide. The program examines the topics, industries and community institutions shaping daily life, with educational features intended for a general audience. More information is available at allaccessptv.com

About AlignRx: AlignRx is the nation's largest independently owned PSAO, representing nearly 5,300 community pharmacies across the USA and Puerto Rico. The company empowers pharmacy businesses with comprehensive, data-driven solutions built to streamline operations. At AlignRx, every pharmacy selects their own wholesaler or buying group. Its mission is to ensure the vitality and growth of community pharmacy. Learn more at alignrx.org

SOURCE All Access

Share this article

- 2026 WRC season finale to take place from October 1 to 4 around Alghero, Sardinia, Italy

- Dynapro R213 all-terrain rally tires engineered for rugged terrain, including rocky sections

- Hankook demonstrates global motorsport expertise through exclusive WRC tire supply and data accumulated across approximately 70 competitions worldwide

ALGHERO, Italy, Oct. 1, 2026 /PRNewswire/ -- A leading global tire company Hankook Tire & Technology (Hankook), the exclusive tire supplier to the FIA World Rally Championship (WRC), is set for the final round of the season, Rally Italia Sardegna, taking place from October 1 to 4 around Alghero on the island of Sardinia, Italy.

Now in its 23rd edition, Rally Italia Sardegna is a historic gravel event. With Rally Saudi Arabia, originally scheduled as the final round, removed from the WRC calendar, the Italian contest will close out the 2026 season. As the Drivers' Championship will be decided here, strategies for tackling demanding roads and unpredictable October weather, along with tire performance, are expected to play a crucial role.

The rally comprises 17 Special Stages (SS) covering approximately 307.02 competitive kilometers on unpaved roads. Narrow, winding sections bordered by trees and undergrowth, together with blind crests, limit visibility and leave little room for error.

The route also features Micky's Jump, one of the event's best-known sections, alongside deep ruts formed by repeated runs and rough rocky stretches. These elements place high demands on tire durability and vehicle stability, making consistent control a key factor throughout the rally.

Hankook will supply the Dynapro R213, its all-terrain rally tire, in Hard and Soft compounds to support teams through the season-ending event. The tire is designed to absorb impacts from gravel while providing stable grip and precise handling and robust durability across demanding stages.

At Round 12, Rally Chile Biobío, Toyota GAZOO Racing World Rally Team's Oliver Solberg claimed his second victory of the year following his win at Rallye Monte-Carlo. The result secured Toyota the 2026 Manufacturers' Championship, marking the team's sixth consecutive title since 2021 and its 10th overall. With the manufacturers' crown decided, the Drivers' Championship will be settled at Rally Italia Sardegna.

Hankook demonstrates its world-class motorsport technology as the exclusive rally tire supplier across all WRC classes. By actively leveraging extensive driving data accumulated across approximately 70 motorsport competitions worldwide, including the WRC, in its research and development (R&D), the company drives innovation in high-performance tire technology while strengthening its competitiveness as a global top-tier brand.

Share this article

Coalition seeks an effective and fair EU approach for responsible biometric travel to protect passenger choice, privacy and fundamental rights.

COURBEVOIE, France, Oct. 1, 2026 /PRNewswire/ -- ACI EUROPE, Amadeus, IATA, IDEMIA Public Security and SITA today announced the formation of the Responsible Biometrics Travel Industry Coalition, calling on EU policymakers to ensure the Digital Omnibus actively supports the voluntary and secure use of biometrics in travel while protecting passenger choice and privacy.

The coalition is seeking a balanced regulatory approach that enables a more efficient and convenient experience for air travelers and maintains strong safeguards around the responsible use of biometric technologies.

The Digital Omnibus is intended to simplify Europe's digital rulebook, support innovation and strengthen competitiveness. It also preserves high standards of data protection and cybersecurity. Yet the legislative proposal could place unintended restrictions on the voluntary use of biometrics by passengers across Europe.

The coalition is urging policymakers to ensure the Digital Omnibus preserves passenger choice and allows citizens to benefit from the opportunities that biometrics can offer.

Why Biometrics Matter

Biometrics make travel more seamless for passengers and deliver significant operational benefits for airports and airlines. By reducing repeated manual document checks, biometric verification increases throughput, improves passenger flows and helps airports use existing terminal infrastructure more efficiently. It also helps airports better manage peak periods and traffic growth, allowing staff to focus on passengers who need assistance or additional attention.

Combined, these benefits boost Europe's competitiveness by promoting efficient, well-connected airports and innovation across the travel and technology sectors. A clear regulatory framework can encourage continued investment and enable European technology companies to innovate and scale trusted solutions in their home market.

To unlock the full potential of biometrics in European air travel, the coalition calls for the Digital Omnibus to adopt technology-neutral rules that allow the voluntary use of biometric data (where appropriate safeguards are in place) and offer passengers non-biometric alternatives.

Protecting Privacy and Passenger Choice

The coalition firmly believes the benefits of biometrics should go hand in hand with strong protections for passenger privacy and passengers' ability to choose whether to share or request to delete their data at any time. The use of biometric solutions should be voluntary, secure and limited to a defined journey.

Research cited by the coalition found that 74% of travelers surveyed were willing to share biometric data in place of showing a passport or boarding pass, according to IATA's Global Passenger Survey.

Manifesto

"EU policymakers have the opportunity to put Europe in the global lead on biometric regulation. The benefits of the latest technologies are clear: they can protect passenger data privacy and open a more seamless and efficient travel process. This will enhance the region's overall competitiveness. At the same time, biometric journeys should always be based on passenger choice and voluntary participation.

Today we are publishing a manifesto that cements industry commitments to responsible use of biometrics and sets out a regulatory call for action to adopt rules that facilitate a secure and seamless future for more than a billion European air travelers each year," the Coalition said.

The Coalition includes senior representatives from each member organization: Olivier Jankovec, Director General, ACI EUROPE; Fernando Cuesta, Senior Vice President, Industry Affairs Global Development, Amadeus; Thomas Reynaert, Senior Vice President, External Affairs, IATA; Lisa Shoemaker, Senior Vice President, Corporate Relations, IDEMIA Public Security; Pedro Alves, Senior Vice President, Borders, SITA.

The 'Advancing Responsible Biometrics in Europe' Manifesto outlines a balanced, evidence-based approach to biometric technologies with the aim of:

- Supporting public-private dialog on biometrics to help Europe respond to growing passenger volumes and limited airport capacity, while strengthening the competitiveness of its transport and tourism sectors.1

- Promoting greater legal clarity around the use of biometric data to facilitate the responsible deployment of technologies that can bring tangible benefits to travelers.

The coalition brings together expertise from across the travel ecosystem to provide practical insights and engage with policymakers and regulators. Coalition members believe that continued collaboration between industry and public authorities will be essential to maintaining Europe's high standards of privacy and fundamental rights while enabling future innovation in travel.

About ACI EUROPE 

ACI EUROPE is the European region of Airports Council International, the only global trade association for airports. We represent over 600 airports in 55 countries. Our members facilitate over 95% of commercial air traffic in Europe. Air transport supports 14 million jobs, generating €851 billion in European economic activity (5% of GDP). In response to the Climate Emergency, in June 2019 our members committed to achieving Net Zero carbon emissions for operations under their control by 2050, without offsetting. Based in Brussels, we lead and serve the European airport industry and maintain strong links with other ACI regions throughout the world. 

About Amadeus 

Amadeus makes the experience of travel better for everyone, everywhere by inspiring innovation, partnerships and responsibility to people, places and planet. 

As the system of record in travel, its technology powers the travel and tourism industry, enabling airlines, airports, hotels, travel sellers and partners to operate at global scale. Built on decades of industry expertise, its open platform connects hundreds of systems and workflows across the end-to-end journey, helping the industry respond to evolving traveler expectations and transforming how travel works.

Amadeus is an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC, and has been recognized by the Dow Jones Best-in-Class World Index for 14 consecutive years.

Amadeus. It's how travel works better.

Learn more about Amadeus at www.amadeus.com/.

About IATA  

The International Air Transport Association (IATA) is the trade association for the world's airlines, representing over 370 airlines accounting for some 85% of global air traffic. We support many areas of aviation activity and help formulate industry policy on critical aviation issues.    

IATA's mission is to represent, lead, and serve the airline industry. 

www.iata.org 

About IDEMIA Group  

IDEMIA Group is a global technology leader with more than 12,500 employees worldwide. Its two market-leading divisions deliver mission-critical solutions that simplify and secure interactions in the physical and digital realms: 

- IDEMIA Secure Transactions (IST) is the leading technology provider making it safer and easier to pay and connect. With unmatched expertise in cryptography and credential issuance, IST is trusted by over 2000 financial institutions, mobile operators, automotive manufacturers, and IoT providers worldwide. Every day, IST secures billions of essential transactions, ensuring the highest levels of data protection and convenience. 

- IDEMIA Public Security (IPS) is a trusted provider of government-grade and secure biometric-based solutions for 600 government, state and federal agencies. With decades of experience in biometric technologies, IPS enables safer, frictionless and fairer ways to secure travel, access and citizen protection.

For more information, please visit www.idemia.com.

About SITA  

SITA is the air transport industry's tech engine, making travel safer, easier, and more sustainable for everyone. From the earliest days of commercial aviation to today's digital frontiers, SITA has been there, connecting the industry and helping it evolve through every leap forward.  

With around 2,500 customers, SITA technology supports over 1,000 airports and more than 19,600 aircraft worldwide. It also helps over 70 governments strike the balance between secure borders and seamless journeys. Behind the scenes, SITA bridges 45–50% of the industry's data exchange, enabling a highly complex global network to operate smoothly and reliably, every step of the way.

Owned by the industry and driven by its needs, SITA operates in more than 200 countries and territories.

Find out more at www.sita.aero.

Media contacts:

Agata Lyznik  

ACI EUROPE 

+32 2 552 09 89 

[email protected] 

Kristen Goldman  

Amadeus 

+1 781 330 6539 

[email protected] 

Chris Goater 

IATA 

+41 227 702 615 

[email protected]  

Genevieve de Vera 

IDEMIA Public Security          

+1 978 808 7047 

[email protected] 

Charles Font 

SITA 

+34 663 805 550 

[email protected]  

1 ICAO forecasts that global air passenger traffic will reach 12.4 billion passengers annually by 2050, nearly three times 2024 levels. Digital identity and biometric technologies can help airports process growing passenger volumes more efficiently, make better use of existing infrastructure and support a secure, seamless passenger experience.

Share this article

INFORM Launches Aviation Software for Passenger Assistance Operations

As surging passenger assistance demand strains global airports, INFORM's Passenger Assistance (PA) Dispatching software delivers predictive forecasting, real-time control, and decision support to boost service quality and operational efficiency

AACHEN, Germany and ATLANTA, Oct. 1, 2026 /PRNewswire/ -- INFORM, a global leader in AI-driven logistics and operational optimization solutions, introduces Passenger Assistance (PA) Dispatching, a cloud-native SaaS solution designed specifically for passenger assistance operations.

Passenger assistance is growing increasingly complex. Rising traveler volumes, higher service expectations, staffing shortages, and frequent disruptions force dispatchers to make rapid decisions to protect service standards. Reliance on manual processes and fragmented operational data prevents teams from responding proactively to real-time changes.

INFORM's Passenger Assistance (PA) Dispatching software addresses these challenges across PRM, unaccompanied minor, VIP, and special assistance operations. By unifying predictive forecasting, real-time visibility, and decision support, the platform accelerates response times and sharpens operational decisions—integrating easily into existing airport systems via standardized interfaces.

"The challenge is not a lack of data," explains Dr. Eva Wille, Product Manager for PA Dispatching at INFORM. "Most organizations already have a lot of information available. The real question is how to turn that information into better decisions while operations are running. Passenger assistance teams need to know what requires attention right now, what is likely to happen next, and where they should focus their resources."

Powered by INFORM's decision intelligence and decades of airport expertise, PA Dispatching enables teams to anticipate demand, spot bottlenecks, and allocate resources efficiently. Dispatchers benefit from real-time visibility and actionable recommendations, while field staff stay connected via mobile workflows and live updates. The result is an agile operation that preserves service quality, optimizes workforce use, and adapts swiftly to last-minute disruptions.

Dr. Johannes Richenhagen, Senior VP at INFORM Aviation, added: "PA Dispatching marks the launch of our future-ready product strategy. Built cloud-native and AI-native, it is simple to implement, intuitive to use, and designed to integrate seamlessly into existing workflows while scaling with operational growth. Paired with our Performance Products, it gives our customers clear flexibility on their journey toward decision intelligence."

About INFORM

INFORM develops software that optimizes decision-making across aviation, industrial, logistics, and financial sectors. Founded in 1969, the company combines explainable AI (XAI) and operations research to help more than 2,000 global customers minimize risk, boost operational efficiency, and make reliable, data-driven decisions.

Press Contact

Elke Jäger

INFORM GmbH

Phone Office: +49 2408 9456-1433 I Mobile: +49 151 14884 265

E-mail: [email protected] 

North America

Valerie Harding

Phone: +1 (0) 617-536-8887

E-mail: [email protected] 

Share this article

Skanska to build and renovate academic buildings in Fredericksburg, USA, for USD 163M, about SEK 1.5 billion

STOCKHOLM, Oct. 1, 2026 /PRNewswire/ -- Skanska has signed a contract with the University of Mary Washington for the construction of a new theatre and the renovation of fine arts buildings in Fredericksburg, Virginia, USA. The contract is worth USD 163M, about SEK 1.5 billion, which will be included in the US order bookings for the third quarter of 2026.

The full project scope includes site development, infrastructure, core shell and interior fittings for a new multi-story, approximately 6,300 square-meter (68,230-square-foot) theatre with 293-seat performance hall. The project also includes 7,600 square meters (82,000 square feet) of renovations in the existing fine arts buildings and an 800 square meter (8,950-square-foot) addition.

The project has begun and construction and renovations are expected to reach completion in February 2030.

For further information please contact:

Jessica Wheeler, Communications Director Southeast, Skanska USA, tel +1 919 717 3429

Andreas Joons, Press Officer, Skanska AB, tel +46 76 870 75 51

Direct line for media, tel +46 (0)10 448 88 99

This and previous releases can also be found at www.skanska.com/group.

This information was brought to you by Cision http://news.cision.com.

The following files are available for download:

SOURCE Skanska

Share this article